Immunogenicity of a combined Diphtheria-Tetanus-Acellular Pertussis (DT-tricomponent Pa)-Hepatitis B (HB)-Inactivated Poliovirus (IPV) admixed with Haemophilus …

MM Blatter, KS Reisinger, DR Terwelp… - Pediatric …, 1998 - nature.com
An open, randomized, multicenter trial studied the immunogenicity and safety of a combined
DTPa-HB-IPV admixed with Hib vaccine (mfr by SB Biologicals) given as a single injection …

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

SA Halperin, L Sweet, D Baxendale… - The Pediatric …, 2006 - journals.lww.com
Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …

[HTML][HTML] Effectiveness of DTaP Against Pertussis in≤ 2-Year-Old Children—Linyi Prefecture, Shandong Province, China, 2017–2019

P Zhu, D Wu, Y Wang, X Liu, LE Rodewald, Y Li… - China CDC …, 2023 - ncbi.nlm.nih.gov
Vaccine effectiveness (VE) is positively correlated with the number of administered co-
purified diphtheria, tetanus, and acellular pertussis vaccine (DTaP) doses. A matched case …

New combined tetanus-diptheria-acellular pertussis vaccines for adults: primary care physician attitudes and preferences

MM Davis, K Kretsinger, AE Cowan, S Stokley… - Human …, 2007 - Taylor & Francis
Availability of combined tetanus-diphtheria-acellular pertussis (Tdap) vaccines for adults
offers a new pertussis prevention strategy for the US. Successful uptake of Tdap vaccine will …

Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®) A Review of its Use as a Single-Dose Booster Immunization in …

GL Plosker - BioDrugs, 2009 - Springer
Boostrix® is a three-pertussis component, combined, reduced-antigen content tetanus,
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …

Effects of a minimum interval immunization schedule for diphtheria and tetanus toxoids and acellular pertussis vaccination during a pertussis outbreak

D Bronson-Lowe, SM Anderson - Archives of pediatrics & …, 2009 - jamanetwork.com
Objective To examine the impact of a minimum interval schedule for administering
diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) in infants during a …

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell …

K Stehr, JD Cherry, U Heininger, S Schmitt-Grohé… - …, 1998 - publications.aap.org
Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …

Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history

S Larnaudie, N Guiso, C Baptiste, C Desaint… - Human …, 2010 - Taylor & Francis
This study was to assess the humoral immune response induced by a vaccination schedule
routinely used in France in 18-50 year old adults with unknown vaccination history. In this …

A fourth dose of DTPa-IPV vaccine given to 4–6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11–12 months of age

L Nilsson, G Faldella, JM Jacquet… - … journal of infectious …, 2005 - Taylor & Francis
Healthy 4–6 y old children from Italy and Sweden immunized with DTPa and inactivated or
oral polio vaccines at 3, 5 and 11–12 months of age, received 1 dose of combined DTPa-IPV …

Diphtheria, tetanus, and pertussis: unequal vaccine siblings with distinct characteristics

U Heininger - Clinical Infectious Diseases, 2021 - academic.oup.com
To the Editor—With great interest I read the article by Slifka et al [1] who reported convincing
evidence that performing regular booster vaccinations against diphtheria and tetanus in …